InsidersTradesSigma
Follow the Hamlet Biopharma AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Market capitalisation: €97.1m. The latest transaction was disclosed on 3 August 2026 (Sale). Among the most active insiders: Henrik Sundin. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Hamlet Biopharma AB (publ) is a Swedish biopharmaceutical company listed on the Stockholm Stock Exchange. It focuses on developing innovative treatments for cancer.